Applying Network Meta-Analysis to Cardiovascular Outcome Trials of Glucose-Lowering Drugs

被引：1
|
作者：
Zheng, Sean L. [1 ]
Roddick, Alistair J. [1 ]
机构：
[1] Imperial Coll London, Dept Cardiol, Fac Med, Kings Coll Hosp NHS Fdn Trust, 33 Willcott Rd, London SE5 9RS, England
来源：
JACC-HEART FAILURE | 2018年 / 6卷 / 12期
关键词：
D O I：
10.1016/j.jchf.2018.09.004
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1052 / 1052
页数：1
相关论文
共 50 条
  • [41] Potential of glucose-lowering drugs to reduce cardiovascular events
    Zarich, Stuart W.
    CURRENT DIABETES REPORTS, 2009, 9 (01) : 87 - 94
  • [42] Evaluation of glucose-lowering medications in older people: a comprehensive systematic review and network meta-analysis of randomized controlled trials
    Pan, Ssu-Yu
    Su, En-Lin
    Huang, Chi-Jung
    Chuang, Shao-Yuan
    Chiang, Chern-En
    Chen, Chen-Huan
    Cheng, Hao-Min
    AGE AND AGEING, 2024, 53 (08)
  • [43] Potential of glucose-lowering drugs to reduce cardiovascular events
    Stuart W. Zarich
    Current Diabetes Reports, 2009, 9 : 87 - 94
  • [44] Comparison of the effect of glucose-lowering agents on the risk of atrial fibrillation: A network meta-analysis
    Shi, Wence
    Zhang, Wenchang
    Zhang, Da
    Ren, Ge
    Wang, Pengfei
    Gao, Lihua
    Chen, Haonan
    Ding, Chunhua
    HEART RHYTHM, 2021, 18 (07) : 1090 - 1096
  • [45] Effects of novel glucose-lowering drugs on the COVID-19 patients with diabetes: A network meta-analysis of clinical outcomes
    Yang, Yang
    Zhao, Ling
    Wang, Yeying
    Liu, Chengjiang
    Ke, Tingyu
    INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2024, 44 (03) : 426 - 436
  • [46] Cardiovascular outcome trials glucose-lowering drugs or strategies in type 2 diabetes (vol 383, pg 2008, 2014)
    Holman, R. R.
    Sourij, H.
    Califf, R. M.
    LANCET, 2014, 383 (9936): : 2212 - 2212
  • [47] Diabetes drugs and stroke risk: Intensive versus conventional glucose-lowering strategies, and implications of recent cardiovascular outcome trials
    Lim, Soo
    Oh, Tae Jung
    Dawson, Jesse
    Sattar, Naveed
    DIABETES OBESITY & METABOLISM, 2020, 22 (01): : 6 - 15
  • [48] Glucose-Lowering and the Risk of Cardiovascular Events With Antidiabetic Therapies: A Systematic Review and Additive-Effects Network Meta-Analysis
    de Carvalho, Luiz Sergio Fernandes
    Nogueira, Ana Claudia Cavalcante
    Bonilha, Isabella
    Luchiari, Beatriz
    Benchimol, Alexander
    Couri, Carlos Eduardo Barra
    Borges, Jairo Lins
    Barreto, Joaquim
    Sposito, Andrei C.
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [49] Newer glucose-lowering drugs and risk of dementia: A systematic review and meta-analysis of observational studies
    Tang, Huilin
    Shao, Hui
    Shaaban, C. Elizabeth
    Yang, Keming
    Brown, Joshua
    Anton, Stephen
    Wu, Yonghui
    Bress, Adam
    Donahoo, William T.
    DeKosky, Steven T.
    Bian, Jiang
    Guo, Jingchuan
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2023, 71 (07) : 2096 - 2106
  • [50] Incretin-based glucose-lowering medications and the risk of acute pancreatitis and malignancies: a meta-analysis based on cardiovascular outcomes trials
    Abd El Aziz, Mirna
    Cahyadi, Oscar
    Meier, Juris J.
    Schmidt, Wolfgang E.
    Nauck, Michael A.
    DIABETES OBESITY & METABOLISM, 2020, 22 (04): : 699 - 704
12345